• Blog
  • Pricing
  • Contact
  • FAQ
Sign InSign Up
AI Agent for Financial MarketsAsk anything. Our AI Agent brings real-time data and full market coverage.Open chat
MarketsStocksCryptoForexCommoditiesCalendarInsiders
CTNM

CTNM

Contineum Therapeutics, Inc. Class A Common Stock

NASDAQHealthcareBiotechnologyUS

USD12.48

+0.10 (+0.81%)

Rating:C+

Company Profile

CEO

Carmine N. Stengone

IPO Date

2024-04-05

Sector

Healthcare

Industry

Biotechnology

Exchange

NASDAQ

Country

US

Market Metrics

Open

$12.43

Prev. Close

$12.38

Day Low

$12.20

Day High

$12.79

52W Low

$3.57

52W High

$16.33

Market Cap

$0.47B

Volume

0.43M

OverviewFinancialsRatingsInsidersSentimentsChart Patterns
Analyst Consensus
Buy

Strong Buy

0

Buy

2

Hold

1

Sell

0

Strong Sell

0

Analyst Grades
DateFirmPreviousNew GradeAction
14 May 2026Morgan StanleyEqual WeightEqual Weightmaintain
6 Mar 2026BairdOutperformOutperformmaintain
8 Jan 2026Morgan StanleyOverweightEqual Weightdowngrade
24 Nov 2025
Baird
Outperform
Outperform
maintain
21 Nov 2025RBC CapitalOutperformOutperformmaintain
18 Aug 2025Morgan StanleyOverweightOverweightmaintain
19 May 2025Morgan StanleyOverweightOverweightmaintain
15 May 2025RBC CapitalOutperformOutperformmaintain
7 Mar 2025BairdOutperformOutperformmaintain
9 Jan 2025RBC CapitalOutperformOutperformmaintain